Research programme: punctal plug therapeutics - Mati Therapeutics

Drug Profile

Research programme: punctal plug therapeutics - Mati Therapeutics

Alternative Names: Difluprednate - punctal plug; Nepafenac - punctal plug; Prostaglandin analogue - punctal plug

Latest Information Update: 07 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mati Therapeutics
  • Class Prostaglandins; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors; Prostaglandin receptor agonists; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Glaucoma; Inflammation; Pain

Most Recent Events

  • 03 Oct 2016 Early research in Pain, Glaucoma and Inflammation in USA (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top